DrugInfoSys

Digitoxin

Drug #240

Medicinal plants containing cardiac glycosides were known to the ancient Egyptians 3000 years ago, but these agents were used randomly and with variable success until the 18th century, when William Withering an English physician and botanist, published a monograph describing the clinical effects of an extract of the foxglove plant i.e., Digitalis purpurea in 1785, described in detail the indication for use of cardiacglycoside. Digitoxin is a cardiac glycoside obtained from Digitalis purpurea and other suitable species of of Digitalis, containing 3 molecules of digitxose linked to digitoxigenin. It has both lipophilic (steroid nucleus) and hydrophilic (lactone ring, hydroxyl, sugar) groups. It makes the heart function more efficient. It increases the force of contraction of heart and slows heart rate, used to treat congestive heart failure, to control ventricular rate in the treatment of supraventricular dysrhythmias including atrial fibrillation and flutter, and to treat paroxysmal atrial tachycardia. Digitoxin is administered orally, intramuscularly or intravenously.

Primary Characteristics

Digitoxin is also known as Crystodigin.

It is of Natural origin and belongs to Glycoside.

It belongs to Sodium Potassium atpase inhibitor pharmacological group on the basis of mechanism of action and also classified in Anti arrhythmic agents pharmacological group. It is also classified under Cardiac Glycosides .

Molecular Weight: 764.9 · pKa: unionized · Solubility in Water: almost insoluble · Solubility in Alcohol: 1 in 150 · Non-proprietary name: Digitoxin.

Molecular structure of Digitoxin

Pharmacokinetics

Absorption: Digitoxin has an oral bioavailability is 92.5% (±2.5%).

Distribution: Digitoxin has a volume of distribution is 0.5 l/kg. plasma protein binding is >90%.

Elimination: it is metabolised via hepatic, plasma half-life is 3-16 days or avg. 7.5 days, renal excretion is 75%.

Advertisement

Indications

Contraindications

Dosage

Digitoxin's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
85 ug85 ugEvery 24hIVBut injections may may cause irritation.
1.75 ug/kg1.75 ug/kgEvery 24hPO Maintenance, As Required
5.84 ug/kg5.84 ug/kgEvery 24hPOLoad for 3-days.
Paediatric Dosage (20kg)
20 ug/kg20 ug/kg
Neonatal Dosage (3kg)
No data.

Drug Interactions

Unknown20 interactions
3 interactions
Moderate2 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Digitoxin in overdosage may give rise to further complications which include Thrombocytopenia , Hypersensitivity reactions , Ventricular tachycardia , Ventricular fibrillation , Supraventricular extra beats , Color vision disturbance, Sinus bradycardia , Heart block , Gynacomastia .

Digitoxin produces potentially life-threatening effects which include Cardiac arrhythmias. Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Digitoxin are Heart block, Hyperkalemia, Ventricular arrhythmias.

Digitoxin is known to cause more or less tolerable side effects which are usually transient. These include Agitation , Amnesia , Anorexia , Confusion, Delirium , Dizziness, Drowsiness, GI symptoms, Nausea, nervousness, PR interval prolongation, Restlessness, Vomiting .

Warnings / Precautions

Digitoxin should be used with caution in patients with history of liver, kidney, thyroid or lung diseases. If patient have ever had rheumatic fever. Food high in fiber may decrease the absorption of digitoxin, be sure to take digitoxin a few hours before or after eating something high in fiber (such as bran). If normal activity causes shortness of breath or if patient awakens frequently during the night due to shortness of breath, tell the doctor. Do not change the dose without consulting the doctor. Before having surgery, including dental surgery, tell the doctor about the use of digitoxin. This medication should be used only when clearly needed during pregnancy or lactation.

Interference in Pathology

Digitoxin may interfere in the diagnosis of No well documented.

Available Brands

None recorded.

Storage Conditions

Digitoxin should be stored Tab.

Drug Classification

  1. 1.12.2Antiarrhythmic drugs
  2. 2.12.4Drugs used in heart failure